COMPARE · Reviewed August 7, 2026
DVA vs FMS
Verdict: Side-by-side breakdown using the Bull Rankings model. DVA scored 68.4, FMS scored 72.4 — FMS leads.
Compare another set
Different reporting periods. DVA's fundamentals are as of June 2026, but FMS's are as of December 2016 — a 116-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
DVA
DaVita Inc.
68.4
$183.77 · $11.7B
fundamentals as of
Score gap
4.0
FMS leads
FMS
Fresenius Medical Care AG
72.4
$24.27 · $12.9B
fundamentals as of
The model, pillar by pillar (0–100 each)
DVA
stronger →← stronger
FMS
69
Qualityreturns · margins · balance sheet
74
68
Growthrevenue & earnings expansion
75
68
Valuevaluation vs sector peers
80
FMS is stronger on 3 of 3 pillars.
Fundamentals, head-to-head
DVA
FMS
$1.6bC+
FCF
$1.1bC+
+6.4%C+
Rev
+5.9%C+
—
D/E
0.81C+
15.6xA-
P/E
12.7xA-
0.73A-
PEG
0.89B+
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
DVA
FMS
66% below
Price vs fair valuelower is cheaper
57% below
~-16%/yr
Growth the price implies10-yr FCF · lower = less priced in
~-6%/yr
+153%
1-yr DCF upside
+76%
+198%
5-yr DCF upside
+132%
+278%
10-yr DCF upside
+250%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
DVA
Why this score
- Buying back stock
- Durable high returns
FMS
Why this score
- Buying back stock
- Foreign reporter (EUR)
The companies
DVADaVita Inc.
Why now
Medical Care Facilities · market cap $11.7b. Down 26% from 52-week high of $247.49 — deep drawdown territory. PEG 0.73 — paying under fair value for the growth rate. 7 sell-side analysts publish a mean 1-yr target of $208.57 (implying +13% upside).
Moat
FCF converts 136% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
ROE -154% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
FMSFresenius Medical Care AG
Why now
Medical Care Facilities · market cap $12.9b. 12% off the 52-week high of $27.64. PEG 0.89 — paying under fair value for the growth rate. 7 sell-side analysts rate this a Hold with a mean 1-yr target of $25.80 (implying +6% upside).
Moat
Net margin 24% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 12% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.